Immunomodulators and delivery systems for vaccination by mucosal routes.
about
Regulation of lung immunity and host defense by the intestinal microbiotaCochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisationDynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunizationDefect density in multiwalled carbon nanotubes influences ovalbumin adsorption and promotes macrophage activation and CD4(+) T-cell proliferationIntranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challengeAdenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.Intranasal coadministration of the Cry1Ac protoxin with amoebal lysates increases protection against Naegleria fowleri meningoencephalitis.Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responsesCurrent advances in antifertility vaccines for fertility control and noncontraceptive applications.Protectivity conferred by immunization with intranasal recombinant outer membrane protein H from Pasteurella multocida serovar A:1 in chickens.Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge.Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants.Alternative routes of mucosal immunization in large animals.A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV.Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepaciaOral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.Starch microparticles as vaccine adjuvant.Materials that harness and modulate the immune system.Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.Implication of nanoparticles/microparticles in mucosal vaccine delivery.Effects of infection with transmissible gastroenteritis virus on concomitant immune responses to dietary and injected antigens.Mucosal Vaccine Development Based on Liposome Technology.Archaeal lipid mucosal vaccine adjuvant and delivery system.Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines.Novel approaches to oral immunization for hepatitis B.Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches.Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.Characterization of the porcine neonatal Fc receptor--potential use for trans-epithelial protein delivery.Development of enhanced antibody response toward dual delivery of nano-adjuvant adsorbed human Enterovirus-71 vaccine encapsulated carrier.Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus.Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.Surface display of OmpC of Salmonella serovar Pullorum on Bacillus subtilis spores.Safety of intranasally administered archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) vaccine in mice.Curdlan sulfate-O-linked quaternized chitosan nanoparticles: potential adjuvants to improve the immunogenicity of exogenous antigens via intranasal vaccination.
P2860
Q26779232-BA8A7E25-E385-40C3-B9C5-454F9B3C9D67Q27316184-C2280132-0CFF-4FE6-84DD-99AF6ADE8EFCQ27320722-621B51BA-13DA-4758-BF21-1FB05BF73DBDQ28388944-4E1EE5CA-073A-4379-9B63-601945F773F2Q28743895-9DE3988E-42BA-4802-A5C1-88E9DC6AD6F1Q30449654-EE5A1201-B872-416C-A980-28E26AAEFECAQ34044951-286D22C8-340C-4A92-9576-790770516FB8Q34183386-07E8C8F8-724A-4B75-9763-D097D28406B1Q34335523-591B499C-5263-4EA8-BE1D-03A4FE6E3CDBQ34852816-85908CCD-327F-41D5-985D-F6C01B491688Q35193494-8330E60E-AB8E-456D-8569-6D53C5A5F143Q35252487-21AD66AA-FD14-4EC8-8A17-9C6E9B2420F8Q35545292-E3D86598-A92E-492D-A965-3EA572D1E78EQ35593603-45A50A9B-F5EF-4565-BEE7-8969BE5E0B65Q35675891-9C43355A-86EF-4D05-845A-F89C4A696418Q35757125-1F090189-0660-4634-90BD-95FAB4BA6200Q35913531-F555BB62-0100-4016-B924-408B2D0F7A9EQ36260414-905FE941-0093-4ABB-9C66-DBF6E620A504Q36316814-96F9D67A-E420-45C8-ABEE-684CE9FC2975Q36690859-ACB91844-6667-4EFA-9B7E-77C6900DF3D8Q36780136-70D8BB9F-DEEF-42EF-A425-030A1FA17101Q36837152-3295C2B5-8F36-43C7-B64A-7B22AD4E07AFQ37015322-3B898576-C2D0-475C-AF10-6D3A10F131ACQ37581129-FFBE981E-F075-4D90-9246-912B4CD1F660Q37724863-27DCCFB6-78D5-4F6B-91EA-72B2B4C03370Q37818335-67B19361-4B8D-40C8-BBB0-E06C6BF5C84CQ37838783-51CC904C-1AD1-425A-B4EC-366F5B823E85Q37867011-E31A2D99-D4BD-4F26-8DC6-525FE8CE7CF8Q38335733-887FCD89-278F-41A2-B89C-6A7049A53B7FQ40440054-86590599-7953-42D2-89B8-B7E726711BD0Q41575418-211C1621-5A50-42C4-AAC5-612F0E88EAF6Q41771428-DEEF58F4-A5D8-48B9-970D-69B23F2236AEQ45105444-BD5B7FDE-534B-4AC7-9E59-5A6B41527D2DQ47433828-0813E22B-0E64-48E9-A8A4-8CC4175BF195Q48165755-066F9602-A281-4F3B-9CE1-D5ECB836AB9FQ48906823-7CDD9606-45FB-487F-B287-14877EAE5E46Q55097822-2052464A-4BDC-474F-911A-F579D2E33390
P2860
Immunomodulators and delivery systems for vaccination by mucosal routes.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunomodulators and delivery systems for vaccination by mucosal routes.
@ast
Immunomodulators and delivery systems for vaccination by mucosal routes.
@en
Immunomodulators and delivery systems for vaccination by mucosal routes.
@nl
type
label
Immunomodulators and delivery systems for vaccination by mucosal routes.
@ast
Immunomodulators and delivery systems for vaccination by mucosal routes.
@en
Immunomodulators and delivery systems for vaccination by mucosal routes.
@nl
prefLabel
Immunomodulators and delivery systems for vaccination by mucosal routes.
@ast
Immunomodulators and delivery systems for vaccination by mucosal routes.
@en
Immunomodulators and delivery systems for vaccination by mucosal routes.
@nl
P1476
Immunomodulators and delivery systems for vaccination by mucosal routes
@en
P2093
P304
P356
10.1016/S0167-7799(01)01670-5
P577
2001-08-01T00:00:00Z